DCT promise

Less burden

Rarely delivered without support

Reality

Redistributed

Same staff, more touchpoints

Solution

Support layer

Independent of site bandwidth

Site operations

Reducing Site Burden in
Decentralized and Hybrid Trials

DCT promised to reduce site burden. In many cases it redistributed it — same staff, more coordination touchpoints, more patient calls, more device troubleshooting. The fix is not better software. It is a patient support infrastructure that operates independently of site bandwidth.

Less coordinator overhead · Better patient support · Protocol adherence

Site
Patient
DCT
Support

Hybrid Trial Support Model

Direct patient support · Site relief

"The coordinator said to call her if I have issues with the app, but she's always busy."
When patient support routes through site staff, everyone loses. A dedicated support layer handles it directly — faster for patients, less burden for sites.

DCT Did Not Reduce Site Burden — It Changed Its Shape

The pitch for decentralized clinical trials included significant reduction in site workload. And in narrow operational terms — fewer patients physically in clinic, fewer blood draws, fewer scheduling conflicts — that is sometimes true. But the broader workload picture is more complicated.

Hybrid trials add coordination overhead that is easy to underestimate at the protocol design stage: technology onboarding calls with patients, troubleshooting wearable devices and eDiary apps, answering questions about at-home procedures, managing home nursing scheduling, and responding to patients who are confused about what they're supposed to be doing this week. None of these tasks disappear in a hybrid model — they just move to a different part of the workflow.

When they default to site coordinators — which they often do, because coordinators are the ones with patient relationships — the net effect on site burden is redistributed effort, not reduced effort. And coordinators who are managing a full clinic schedule on top of DCT coordination overhead make more errors, respond more slowly to patient issues, and experience higher turnover.

See also: Site Enablement · Concierge-as-a-Service™

Reducing site burden in decentralized and hybrid clinical trials

The Real Sources of Added Burden in Hybrid Models

Identifying where burden actually comes from is the prerequisite for addressing it. These are the categories that most commonly appear in hybrid trial retrospectives.

Device and app troubleshooting

Wearable devices, eDiary apps, home spirometry equipment, and other patient-facing technologies generate a continuous stream of support requests. Without a dedicated support function, these land on site coordinators who are not equipped to resolve technical issues quickly.

Patient compliance monitoring

In a pure site-based model, compliance issues surface at visits. In hybrid models, monitoring between visits is continuous — and when a patient falls behind on eDiaries or misses a home assessment, someone needs to notice and act. If that person is the site coordinator, it adds to their burden.

Multilingual patient communication

Hybrid trials often enroll geographically diverse populations. Sites with diverse catchment areas face a disproportionate communication burden when they are responsible for patient outreach in multiple languages.

Home procedure coordination

Home nursing visits, at-home lab sample collections, and remote assessments require scheduling, confirmation, and follow-up. When site coordinators own this workflow, it becomes one of the largest time sinks in hybrid operations.

Consent and re-consent processes

Protocol amendments, wearable additions, and sub-study enrollment all require re-consent. In hybrid trials, coordinating this remotely — while ensuring it is documented correctly — adds significant administrative load.

Technology change management

App updates, device firmware changes, and platform changes require patient re-onboarding. When this falls on site staff, it generates reactive workload spikes that are difficult to plan for.

What Actually Reduces Site Burden

The structural fix is a patient support layer that operates independently of site bandwidth — handling patient communication, compliance monitoring, and technology support directly so site staff can focus on clinical tasks.

Related: Patient Support

Patient support infrastructure that reduces site burden in hybrid trials

FAQ

Is reducing site burden in hybrid trials primarily a technology problem?

No. Technology can surface compliance issues more efficiently, but it does not resolve them. The reduction in site burden comes from taking tasks off site staff — which requires a human support layer, not a better dashboard.

How do you assess site burden risk before a hybrid trial launches?

Map the expected weekly task load per coordinator, including all new tasks added by DCT components. Studies that add five to eight new coordination touchpoints per patient without corresponding support will quickly overwhelm coordinator capacity.

Can a concierge model work for all site types?

Yes, and the value is highest at smaller or community sites with limited coordinator bandwidth. Academic medical centers with dedicated research staff can absorb more DCT overhead — community sites typically cannot, and they are where most patients are enrolled.

Running a Hybrid or Decentralized Trial That Is Stressing Your Sites?

Delve provides direct-to-patient support that operates independently of site bandwidth — reducing coordinator workload while improving patient compliance and retention.

Talk to Our Site Operations Team

See Delve Site Enablement →